Advertisement
Advertisement
Verorab

Verorab

rabies vaccine

Manufacturer:

Sanofi Pasteur

Distributor:

Zuellig
Concise Prescribing Info
Contents
Inactivated rabies vaccine produced in Vero cells
Indications/Uses
Pre- & post-exposure rabies prophylaxis in all age groups.
Dosage/Direction for Use
Pre-exposure prophylaxis Immunocompetent individual Conventional regimen: 0.5 mL IM or 0.1 mL intradermal on day 0, 7, & 21 or 28. 1-week regimen: 0.5 mL IM on day 0 & 7; or 2 doses of 0.1 mL intradermal on day 0 & 7. Individual w/ decreased immunity Follow the conventional 3-dose regimen. Post-exposure prophylaxis Adjusted to exposure category, condition of animal, & vaccination status of the patient in accordance w/ official recommendations. Non-immunised individual & individual w/ decreased immunity IM 0.5 mL on day 0, 3, 7, 14 & 28; or 2 doses of 0.5 mL on day 0, followed by 0.5 mL on day 7 & 21. Intradermal 2 doses of 0.1 mL in 2 separate sites on day 0, 3, 7 & 28; or 2 doses of 0.1 mL in 2 separate sites on day 0, 3 & 7; or 4 doses of 0.1 mL in 4 separate sites on day 0, 3 & 7. Already immunised individual 1 dose (0.5 mL IM or 0.1 mL intradermal) on day 0 & 3. Alternatively, 4 intradermal inj of 0.1 mL in 4 separate sites on day 0.
Contraindications
Pre-exposure: Hypersensitivity. Postpone vaccination in case of fever or acute disease.
Special Precautions
Not to be administered via intravascular route & into the buttocks region. Individuals allergic to polymyxin B, streptomycin, neomycin (present in trace amounts in the vaccine) or to any antibiotic of the same class. Appropriate medical treatment & supervision must be readily available in case of rare anaphylactic reaction after administration. Perform serological tests in accordance w/ official recommendations. Perform blood test 2-4 wk after vaccination in subjects w/ immunodeficiency to ensure that protective immunising response was obtained. Risk of bleeding during IM administration in patients w/ thrombocytopenia or clotting disorders. Contains phenylalanine. Can temporarily affect ability to drive or use machines.
Adverse Reactions
Generally feeling unwell, cephalalgia, myalgia, inj site pain, erythema or swelling; irritability, inconsolable crying & drowsiness in babies. Fever, lymphadenopathy, allergic reactions (eg, rash & itching), flu-like syndrome, inj site pruritus & induration; difficulty sleeping in babies.
Drug Interactions
Immunosuppressives, including long-term systemic corticosteroid therapy, may interfere w/ Ab production & lead to vaccination failure. Do not combine rabies Ig or any other product & rabies vaccine in the same syringe or inj into the same site.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07BG01 - rabies, inactivated, whole virus ; Belongs to the class of rabies viral vaccines.
Presentation/Packing
Form
Verorab powd for susp for inj 3.25 IU/0.5 mL
Packing/Price
(+ 0.5 mL solvent in pre-filled syringe) 1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement